Your browser doesn't support javascript.
loading
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.
Moran, Gregory J; Fang, Edward; Corey, G Ralph; Das, Anita F; De Anda, Carisa; Prokocimer, Philippe.
Affiliation
  • Moran GJ; Department of Emergency Medicine and Division of Infectious Diseases, Olive View-UCLA Medical Center, CA, USA.
  • Fang E; Clinical Development, Cubist Pharmaceuticals, CA, USA.
  • Corey GR; Division of Infectious Diseases, Duke University Medical Center, NC, USA.
  • Das AF; Biometrics, InClin, CA, USA.
  • De Anda C; Clinical Development, Cubist Pharmaceuticals, CA, USA.
  • Prokocimer P; Clinical Development, Cubist Pharmaceuticals, CA, USA. Electronic address: philippe.prokocimer@cubist.com.
Lancet Infect Dis ; 14(8): 696-705, 2014 Aug.
Article in En | MEDLINE | ID: mdl-24909499
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxazoles / Organophosphates / Skin Diseases, Bacterial / Oxazolidinones / Acetamides / Anti-Bacterial Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2014 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxazoles / Organophosphates / Skin Diseases, Bacterial / Oxazolidinones / Acetamides / Anti-Bacterial Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2014 Type: Article Affiliation country: United States